Events
For over 30 years, PharmaVentures has acted as advisor on over 1,000 deal related projects covering licensing, mergers, acquisitions, divestments, and joint venture activities for companies world-wide
We have unrivalled strategic insight in the commercialisation and transaction of assets and companies in the pharmaceutical, biotech, medtech and diagnostics sectors. We have been trusted by major corporations, high growth biotechs and emerging companies to provide insight and advice to help these businesses achieve their strategic goals. Operating globally in M&A, licensing, divestments and fundraising, we have the skills and experience to help you drive your business forward.
PharmaVentures attends key conferences and meetings to discuss our services and we also attend events on behalf of our clients, promoting advisory mandates in M&A and licensing across the life science sector.
How To Meet Us
We often have opportunities that could be transformative to your business, especially with the optimal strategy and best execution.
Our team attending these events are available to speak with you about your own requirements. To book a meeting, email us at:
Upcoming events
24-26 October 2023
CPHI Barcelona
Andrew Guise and Jansen Jacob will be available for 1-1 meetings.
6-8 November 2023
BIO-Europe
PharmaVentures’ team will be available for 1-1 meetings.
Recent events
20-21 September 2023
23rd Annual Biotech in Europe Forum
Dr Fintan Walton chaired a panel discussion.
19 September 2023
10th Annual HealthTech Investment Forum (HTIF)
Andrew Guise took in a panel discussion and 1-1 meetings.
6 July 2023
ON Helix
Fotis Galiotos took part in 1-1 meetings.
5-8 June 2023
BIO International
PharmaVentures took part in 1-1 meetings.
20-23 March 2023
DCAT Week
Jansen Jacob took part in 1-1 meetings.
20-22 March 2023
BIO-Europe Spring®
PharmaVentures’ team took part in 1-1 meetings.
1-2 March 2023
16th Annual European Life Science CEO Forum
Adrian Dawkes chaired the Pharma Dealmaker’s Roundtable and took part in 1-1 meetings.
28 February 2023
4th Annual European HealthTech CEO Forum
Asif Shahinsha took part in the Investor Roundtable and took part in 1-1 meetings.
9-12 January 2023
BIO One-on-One Partnering™ During JPM Week
PharmaVentures’ team took part in 1-1 meetings.
9-11 January 2023
Biotech Showcase™
PharmaVentures’ team attended 1-1 meetings.
5-8 December 2022
Genesis 2022
Ralph Huges presented Trends in Early Stage Deals: Pricing and Market Access and the team took part in 1-1 meetings.
14-17 November 2022
MEDICA
Asif Shahinsha and Andreas Katsiamides took part in 1-1 meetings.
1-3 November 2022
CPhI Worldwide
Dr Fintan Walton, CEO, chaired the panel discussion: Transactional Strategies to Access Future Therapeutics and Technologies which included Abbvie, Medicxi, Thermo Fisher and PharmaVentures VP, Jansen Jacob.
24-26 October 2022
BIO-Europe®
PharmaVentures’ team took part in 1-1 meetings.